Investment
Features
FeesSafety
Academy
More
Pluang+

Elon Musk named co-director of Pentagon's Project Meridian to explore future warfare tech.

Market News
01 Oct 2026
BeInCrypto
View Source
Neutral
Elon Musk named co-director of Pentagon's Project Meridian to explore future warfare tech.

Elon Musk has been appointed co-director of Project Meridian, a Pentagon initiative to study future warfare technologies including AI and space combat domains. This advisory role, shared with Palmer Luckey and Newt Gingrich, does not grant Musk operational control over troops or budgets. The project aims to identify new battle domains and capabilities, with findings due by January 2027. Musk's previous Pentagon role with the Department of Government Efficiency (DOGE) ended early amid controversy over unverified savings claims.

Elon Musk's Pentagon advisory role is the subject, with Pluang market data providing context. As of Oct 02, 2026 02:41 WIB, 30 of 50 major cryptocurrencies on Pluang rose while 19 fell. Notable moves include XLM at Rp3.940 with a -2.52% change, ONE at Rp40 with +2.43%, and ADA at Rp4.425 with +2.17%.

More News

Foghorn Therapeutics cuts price target after ending Lilly partnership and cutting 40% workforce

Foghorn Therapeutics cuts price target after ending Lilly partnership and cutting 40% workforce

Foghorn Therapeutics saw its price target cut from $12 to $5 after it and Eli Lilly decided not to advance key cancer drug programs. The companies will not continue development of FHD-909 or a selective SMARCA2 degrader, ending their collaboration. F...

Market News
Bearish
1 hour ago
RPM International Q3 2026 earnings expected to show growth with EPS of $1.95 and $2.22B revenue.

RPM International Q3 2026 earnings expected to show growth with EPS of $1.95 and $2.22B revenue.

RPM International is set to report its Q3 2026 earnings on October 6, with analysts forecasting earnings per share of $1.95 and revenue of $2.22 billion, both higher than the previous year. Despite a slight recent dip in the EPS estimate, the report ...

Company Fundamentals
Neutral
1 hour ago
Jefferies raises Regeneron price target to $930 on new $1B Sanofi partnership for antibody drugs

Jefferies raises Regeneron price target to $930 on new $1B Sanofi partnership for antibody drugs

Jefferies increased its price target for Regeneron to $930, citing an expanded partnership with Sanofi to develop four new long-acting antibodies targeting inflammatory pathways. Sanofi will pay Regeneron $1 billion upfront, with potential milestone ...

Analyst Insights
Bullish
2 hours ago
McCormick beats Q3 estimates with 17.4% sales growth despite volume decline

McCormick beats Q3 estimates with 17.4% sales growth despite volume decline

McCormick & Company reported fiscal Q3 results with adjusted EPS of $0.86, surpassing estimates of $0.76, and revenue of $2.02 billion, up 17.4% from last year. Growth was driven by the McCormick de Mexico acquisition, pricing actions, and favorable ...

Company Fundamentals
Bullish
2 hours ago
Aehr Test Systems expects strong Q3 earnings and 160-200% revenue growth in fiscal 2027 driven by AI chip demand.

Aehr Test Systems expects strong Q3 earnings and 160-200% revenue growth in fiscal 2027 driven by AI chip demand.

Aehr Test Systems is set to report Q3 earnings of $0.11 per share and revenue around $27 million, marking a 1,000% increase in earnings year-over-year. The company projects fiscal 2027 revenue growth between 160% and 200%, reaching $130-$150 million,...

Company Fundamentals
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App